Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02604524 · ClinicalTrials.gov registry record · NA

Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp

A NA study of Type 1 Diabetes Mellitus, sponsored by Daniel Chernavvsky, MD, CRC.

Completed
Registry status
NA
Development phase
32
Enrollment target
2
Study locations

NCT02604524: Completed NA study of Type 1 Diabetes Mellitus, sponsored by Daniel Chernavvsky, MD, CRC.

NCT02604524 is a NA study of Type 1 Diabetes Mellitus that has completed, run by Daniel Chernavvsky, MD, CRC. The registered enrollment target is 32 participants, below the 172-participant average among 112 other Type 1 Diabetes Mellitus trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02604524, a NA study of Type 1 Diabetes Mellitus, has completed, sponsored by Daniel Chernavvsky, MD, CRC.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
2
Study locations

Study Summary

The biggest challenges for glycemic control during the day time involve meals and exercise variations, which are impacted by age, fitness level, duration, intensity and history of exercise. Meal variability has the benefit that meals are typically announced and quantified. Glucose control around exercise, on the other hand, is more complicated if the patient doesn't announce a change in activity level.

Conditions Studied

Interventions

  • DEVICE Closed-Loop Control
  • OTHER Sensor Augmented Pump Therapy

Study Locations (2)

Colorado

  • University of Colorado, Denver, Barbara Davis Center - Aurora

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2016-01
Est. Completion 2016-04
Phase NA
Daniel Chernavvsky, MD, CRC

1 total trials

What the finished NCT02604524 record still lists

NCT02604524 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 172-participant average among 112 other Type 1 Diabetes Mellitus trials with a reported enrollment target (81% lower).

The record links to 1 condition, with Type 1 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Closed-Loop Control is the first listed.

NCT02604524 reports a single indexed study location in Colorado, Virginia.

Frequently Asked Questions

What is clinical trial NCT02604524 about?

NCT02604524 is a clinical study titled "Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp". The biggest challenges for glycemic control during the day time involve meals and exercise variations, which are impacted by age, fitness level, duration, intensity and history of exercise. Meal variability has the benefit that meals are typically announced and quantified. Glucose control around exe...

What is the current status of trial NCT02604524?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2016-01. Estimated completion is 2016-04.

What conditions does trial NCT02604524 study?

This clinical trial studies the following conditions: Type 1 Diabetes Mellitus.

What interventions are being tested in trial NCT02604524?

The interventions under investigation include: Closed-Loop Control (DEVICE), Sensor Augmented Pump Therapy (OTHER).

Who is sponsoring clinical trial NCT02604524?

This trial is sponsored by Daniel Chernavvsky, MD, CRC, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02604524 being conducted?

This trial has 2 study locations across Colorado, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02604524's enrollment target sits among peer trials

32 68th of 112 higher than 42 of 112 other Type 1 Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 1 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02604524, the US trial registry maintained by the National Library of Medicine. NCT02604524 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.